SWITCH SWEDEHEART trial shows prasugrel matches ticagrelor with less bleeding
Prasugrel reduced major cardiovascular events to the same extent as ticagrelor but with lower major bleeding after coronary stenting in patients with acute coronary syndromes, according to results from the…